OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect. METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus. RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups. CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.

National Institute of Mental Health Topolova 748 250 67 Klecany Prague East Czech Republic

The Institute of Physiology Academy of Sciences of the Czech Republic v v i Videnska 1083 14220 Prague Czech Republic

Zobrazit více v PubMed

Acta Pharmacol Sin. 2011 Jan;32(1):3-11 PubMed

Neurosci Lett. 2000 Jun 23;287(2):117-20 PubMed

Mol Psychiatry. 2002;7(6):609-16 PubMed

Behav Genet. 2013 Jan;43(1):51-9 PubMed

Stroke. 1995 Mar;26(3):503-13 PubMed

Pharmacol Biochem Behav. 2005 Sep;82(1):200-6 PubMed

Neuropharmacology. 2012 Jan;62(1):35-41 PubMed

Synapse. 2004 Jan;51(1):32-58 PubMed

Neurobiol Learn Mem. 2014 Jan;107:50-64 PubMed

Pharmacol Biochem Behav. 1995 Dec;52(4):701-6 PubMed

Physiol Behav. 1999 Aug 1;67(1):41-7 PubMed

Pharmacol Biochem Behav. 2012 Dec;103(2):220-9 PubMed

Physiol Behav. 2006 Dec 30;89(5):637-43 PubMed

Behav Brain Res. 2014 Oct 15;273:16-22 PubMed

Neurosci Lett. 2007 Jul 18;422(3):169-74 PubMed

Restor Neurol Neurosci. 2011;29(3):153-65 PubMed

Biochemistry (Mosc). 2004 Feb;69(2):176-80 PubMed

J Psychiatry Neurosci. 2009 Jul;34(4):296-302 PubMed

J Neurosci. 2001 Jul 15;21(14):5222-8 PubMed

Basic Clin Pharmacol Toxicol. 2008 Dec;103(6):502-6 PubMed

Front Behav Neurosci. 2013 Aug 08;7:61 PubMed

Pharmacol Biochem Behav. 2015 Feb 21;132:20-32 PubMed

Neurobiol Dis. 2007 Jan;25(1):1-7 PubMed

Biochim Biophys Acta. 2008 Jan;1784(1):116-32 PubMed

Eur J Pharmacol. 2012 Dec 15;697(1-3):59-64 PubMed

Hum Psychopharmacol. 2013 Jan;28(1):87-90 PubMed

Biol Psychiatry. 2013 Aug 15;74(4):250-6 PubMed

Naunyn Schmiedebergs Arch Pharmacol. 2015 Oct;388(10):1079-88 PubMed

Pharmacol Biochem Behav. 2006 Dec;85(4):842-9 PubMed

Biol Psychiatry. 2003 Sep 1;54(5):515-28 PubMed

J Ethnopharmacol. 2012 Aug 30;143(1):158-69 PubMed

Dialogues Clin Neurosci. 2014 Mar;16(1):11-27 PubMed

Neuropharmacology. 2012 Apr;62(5-6):2010-7 PubMed

Exp Neurol. 2007 Mar;204(1):20-8 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):140-4 PubMed

Jpn J Pharmacol. 1995 Feb;67(2):107-15 PubMed

Am J Psychiatry. 2011 Jul;168(7):751-2 PubMed

J Neurosci Methods. 1984 May;11(1):47-60 PubMed

Peptides. 2012 Jun;35(2):160-5 PubMed

Neuro Endocrinol Lett. 2011;32(1):64-76 PubMed

Acta Neurobiol Exp (Wars). 2014;74(3):317-27 PubMed

Psychopharmacology (Berl). 2000 May;150(1):52-60 PubMed

Brain Res Bull. 2003 Jul 15;61(2):159-64 PubMed

Behav Neurosci. 1997 Feb;111(1):80-91 PubMed

J Neuroendocrinol. 2001 Jul;13(7):625-37 PubMed

Brain Res. 1994 Nov 28;665(1):147-50 PubMed

Ann N Y Acad Sci. 1999 Jun 29;877:614-37 PubMed

Neuroscience. 1999;93(1):243-51 PubMed

Behav Brain Res. 2003 Jun 16;142(1-2):63-7 PubMed

Behav Brain Res. 2016 Jan 15;297:5-14 PubMed

Neurosci Lett. 2005 Feb 10;374(2):142-6 PubMed

Neuroscience. 2006;139(3):1017-29 PubMed

Mol Brain. 2014 Apr 24;7:32 PubMed

Eur J Pharmacol. 2009 Apr 17;608(1-3):32-41 PubMed

Psychiatry Res. 2009 Oct 30;169(3):244-8 PubMed

Biol Psychiatry. 2007 Jan 15;61(2):240-5 PubMed

Eur J Neurosci. 2005 Dec;22(11):2871-8 PubMed

J Clin Psychiatry. 2009 Dec;70(12):1662-6 PubMed

Psychopharmacology (Berl). 2015 Jan;232(2):355-67 PubMed

Brain Res. 2011 Mar 10;1378:72-83 PubMed

Psychopharmacology (Berl). 1998 Apr;136(4):394-401 PubMed

Biol Psychiatry. 2012 Jun 1;71(11):939-46 PubMed

Annu Rev Med. 2015;66:509-23 PubMed

Science. 2010 Aug 20;329(5994):959-64 PubMed

Behav Brain Res. 1990 Jul 9;39(2):187-95 PubMed

Br J Anaesth. 2003 Feb;90(2):155-60 PubMed

Biol Psychiatry. 2000 Feb 15;47(4):351-4 PubMed

Brain Res. 2001 Jun 8;903(1-2):242-6 PubMed

Neuropharmacology. 2012 Jan;62(1):270-7 PubMed

Brain Res. 1997 Aug 1;764(1-2):262-4 PubMed

Pharmacol Rev. 2012 Apr;64(2):238-58 PubMed

Psychiatry Res. 2015 Jan 30;225(1-2):1-13 PubMed

Curr Opin Neurobiol. 2009 Apr;19(2):146-53 PubMed

Behav Brain Res. 2012 Apr 15;229(2):320-4 PubMed

Behav Brain Res. 2012 Dec 1;235(2):287-92 PubMed

Sci Signal. 2014 Jul 01;7(332):re2 PubMed

J Mol Neurosci. 2011 Oct;45(2):246-55 PubMed

Biol Psychiatry. 2010 Jun 1;67(11):1017-25 PubMed

Biol Psychiatry. 2012 Feb 15;71(4):317-26 PubMed

Brain Res Cogn Brain Res. 1996 Jun;3(3-4):243-50 PubMed

Eur J Pharmacol. 2015 Apr 15;753:105-13 PubMed

Neurosci Biobehav Rev. 2005;29(4-5):627-47 PubMed

Proc Natl Acad Sci U S A. 2008 Jan 8;105(1):359-64 PubMed

J Affect Disord. 2014 Feb;155:123-9 PubMed

Biol Psychiatry. 2007 Jan 15;61(2):187-97 PubMed

Mol Psychiatry. 2007 Dec;12(12):1079-88 PubMed

Amino Acids. 2002;23 (1-3):213-6 PubMed

Biol Psychiatry. 2011 Apr 15;69(8):754-61 PubMed

Neurobiol Learn Mem. 2008 Jul;90(1):28-35 PubMed

Psychopharmacology (Berl). 1997 Jun;131(3):230-8 PubMed

Nat Rev Neurosci. 2008 Oct;9(10):788-96 PubMed

Pharmacol Biochem Behav. 1996 May;54(1):21-30 PubMed

J Psychiatr Res. 2009 Oct;43(15):1200-4 PubMed

J Neurosci Methods. 2004 Dec 30;140(1-2):81-92 PubMed

Neuropsychiatr Dis Treat. 2015 Jan 17;11:165-75 PubMed

J Pharmacol Exp Ther. 2004 Nov;311(2):427-40 PubMed

Physiol Behav. 1995 Jul;58(1):147-52 PubMed

Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80 PubMed

Trends Pharmacol Sci. 1995 Feb;16(2):33-6 PubMed

Physiol Behav. 1974 Sep;13(3):407-25 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:168-84 PubMed

Stress. 2005 Dec;8(4):209-19 PubMed

Arch Gen Psychiatry. 2006 Aug;63(8):856-64 PubMed

Am J Psychiatry. 2013 Oct;170(10):1134-42 PubMed

Psychopharmacology (Berl). 2011 Aug;216(4):537-44 PubMed

J Neurosci. 2006 Dec 13;26(50):12967-76 PubMed

Ups J Med Sci. 2013 Mar;118(1):3-8 PubMed

J Pharm Pharmacol. 2008 Dec;60(12):1643-50 PubMed

Neurobiol Dis. 2004 Jul;16(2):386-95 PubMed

Eur J Neurosci. 2014 Jan;39(2):266-74 PubMed

Biol Psychiatry. 2005 May 1;57(9):1061-7 PubMed

Mol Psychiatry. 2014 Oct;19(10 ):1106-14 PubMed

Behav Brain Res. 2015 Jun 1;286:104-11 PubMed

Neurosci Biobehav Rev. 2005;29(8):1193-205 PubMed

Biol Psychiatry. 2013 Jun 15;73(12):1133-41 PubMed

Eur Neuropsychopharmacol. 1999 Jan;9(1-2):21-7 PubMed

Endocrinology. 2012 Sep;153(9):4317-27 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1774-9 PubMed

J Psychopharmacol. 2007 Aug;21(6):611-9 PubMed

Behav Brain Res. 2003 Jan 6;138(1):9-15 PubMed

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3531-6 PubMed

Neuropsychologia. 2011 Mar;49(4):651-6 PubMed

Physiol Res. 2013;62 Suppl 1:S1-S19 PubMed

J Neurosci. 2009 Jan 7;29(1):14-22 PubMed

Arch Gen Psychiatry. 2005 Mar;62(3):282-8 PubMed

J Pharmacol Sci. 2007 Feb;103(2):175-80 PubMed

Neuropsychopharmacology. 2012 May;37(6):1526-33 PubMed

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:240-5 PubMed

Arch Gen Psychiatry. 2010 Aug;67(8):793-802 PubMed

Pharmacol Ther. 1997;74(3):299-316 PubMed

Nature. 2011 Jun 15;475(7354):91-5 PubMed